Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19

Samia Berrichi; Zakaria Bouayed; Sara Berrajaa; Sanae El Mezzeoui; Amal Moujahid; Siham Nasri; Houssam Bkiyar; Imane Skiker; Brahim Housni

doi:10.1016/j.amsu.2021.102646

Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19

Ann Med Surg (Lond). 2021 Aug:68:102646. doi: 10.1016/j.amsu.2021.102646. Epub 2021 Jul 29.

Authors

Samia Berrichi¹, Zakaria Bouayed², Sara Berrajaa¹, Sanae El Mezzeoui¹, Amal Moujahid², Siham Nasri², Houssam Bkiyar¹, Imane Skiker², Brahim Housni^{1

3}

Affiliations

¹ Anesthesiology and Intensive Care Unit Department, Faculty of Medicine and Pharmacy Oujda, Mohammed VI University Hospital Center, Mohammed University 1st, Oujda, Morocco.
² Radiology Department, Faculty of Medicine and Pharmacy Oujda, Mohammed VI University Hospital Center, Mohammed University 1st, Oujda, Morocco.
³ Oujda Medical Simulation Training Center, Faculty of Medicine and Pharmacy, Oujda, Morocco.

Abstract

Introduction: Since December 2019, the coronavirus 19 (COVID-19) pandemic continues to spread worldwide and has caused millions of deaths. Although the main manifestation of the disease is acute respiratory distress syndrome, hypercoagulability resulting from hypoxemia leads to venous thromboembolism and arterial thrombosis, which have a fatal prognosis for COVID-19.

Case report management: We report the case of patient admitted to our unit for management of a concomitant limb ischemia, splenic and renal infarcts associated to a COVID-19 infection with favorable outcomes after thrombectomy and therapeutic doses of heparin.

Conclusion: Systemic procoagulant manifestations related to a COVID-19 infection is a newly described phenomenon responsible of cardiovascular and neurological disorders.

Keywords: COVID-19; Limb ischemia; Thromboembolic.

Publication types

Case Reports